Reaction Details Report a problem with these data
Target
Diacylglycerol lipase-beta
Ligand
BDBM50211257
Substrate
n/a
Meas. Tech.
In Vitro Inhibition of DAGL
IC50
<400±n/a nM
Citation
Cravatt, BF; Ogasawara, D; Viader, A; Deng, H; Van Der Wel, T; Van Der Stelt, M Triazole DAGLα inhibitors US Patent US10583137 Publication Date 3/10/2020
More Info.:
Target
Name:
Diacylglycerol lipase-beta
Synonyms:
DAGLB | DGLB_HUMAN | Sn1-specific diacylglycerol lipase beta
Type:
PROTEIN
Mol. Mass.:
73731.79
Organism:
Homo sapiens (Human)
Description:
ChEMBL_557688
Residue:
672
Sequence:
MPGMVLFGRRWAIASDDLVFPGFFELVVRVLWWIGILTLYLMHRGKLDCAGGALLSSYLIVLMILLAVVICTVSAIMCVSMRGTICNPGPRKSMSKLLYIRLALFFPEMVWASLGAAWVADGVQCDRTVVNGIIATVVVSWIIIAATVVSIIIVFDPLGGKMAPYSSAGPSHLDSHDSSQLLNGLKTAATSVWETRIKLLCCCIGKDDHTRVAFSSTAELFSTYFSDTDLVPSDIAAGLALLHQQQDNIRNNQEPAQVVCHAPGSSQEADLDAELENCHHYMQFAAAAYGWPLYIYRNPLTGLCRIGGDCCRSRTTDYDLVGGDQLNCHFGSILHTTGLQYRDFIHVSFHDKVYELPFLVALDHRKESVVVAVRGTMSLQDVLTDLSAESEVLDVECEVQDRLAHKGISQAARYVYQRLINDGILSQAFSIAPEYRLVIVGHSLGGGAAALLATMLRAAYPQVRCYAFSPPRGLWSKALQEYSQSFIVSLVLGKDVIPRLSVTNLEDLKRRILRVVAHCNKPKYKILLHGLWYELFGGNPNNLPTELDGGDQEVLTQPLLGEQSLLTRWSPAYSFSSDSPLDSSPKYPPLYPPGRIIHLQEEGASGRFGCCSAAHYSAKWSHEAEFSKILIGPKMLTDHMPDILMRALDSVVSDRAACVSCPAQGVSSVDVA